Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CEO Stéphane Bancel's: https://mastersofscale.com/bancel2/
In a report released today, Leah R. Cann from Brookline Capital Markets maintained a Buy rating on Moderna (MRNA – Research Report), with a price target of $506.00
https://www.tipranks.com/news/blurbs/moderna-mrna-gets-a-buy-rating-from-brookline-capital-markets?utm_source=advfn.com&utm_medium=referral
Travel heightens monkeypox risks in Asia, experts say!
http://www.chinadaily.com.cn/a/202206/07/WS629ea8b6a310fd2b29e610a6.html
$SIGA
MODERNA ANNOUNCES FIRST PARTICIPANTS DOSED IN PHASE 3 STUDY OF SEASONAL INFLUENZA VACCINE CANDIDATE (MRNA-1010)
https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-First-Participants-Dosed-in-Phase-3-Study-of-Seasonal-Influenza-Vaccine-Candidate-mRNA-1010/default.aspx
Institutional investors and hedge funds have recently made changes to their positions in the business. Advisor Group Holdings Inc. raised its position in SIGA Technologies by 625.0% during the fourth quarter. Advisor Group Holdings Inc. now owns 17,400 shares of the company's stock worth $131,000 after acquiring an additional 15,000 shares during the last quarter. Metropolitan Life Insurance Co NY acquired a new position in SIGA Technologies during the third quarter worth about $90,000. GSA Capital Partners LLP acquired a new position in SIGA Technologies during the third quarter worth about $101,000. Barclays PLC raised its position in SIGA Technologies by 214.0% during the third quarter. Barclays PLC now owns 23,460 shares of the company's stock worth $174,000 after acquiring an additional 15,989 shares during the last quarter. Finally, Strs Ohio raised its position in SIGA Technologies by 27.8% during the fourth quarter. Strs Ohio now owns 102,500 shares of the company's stock worth $770,000 after acquiring an additional 22,300 shares during the last quarter. Institutional investors own 34.52% of the company's stock.
Is the Options Market Predicting a Spike in Moderna Stock....
https://finance.yahoo.com/news/options-market-predicting-spike-moderna-191207634.html
anything could happen!!!!!!!!
Confirmed 1004
Total 1085
https://bnonews.com/monkeypox/
“This report warns that without global co-operation moving forward, the COVID-19 pandemic situation will likely continue until at least 2027. Within the report, three possible scenarios are outlined moving through to 2027 are based upon the advancement and development of the SARS-CoV-2 virus, and the extent and effectiveness of COVID-19 vaccines globally.
https://www.sciencemediacentre.co.nz/2022/05/17/forecasting-the-next-five-years-of-the-covid-19-crisis-expert-reaction/
The White House expects vaccinations of young children to begin in earnest as early as June 21, if federal authorities approve their use in coming weeks, White House COVID response coordinator Ashish Jha said on Thursday.
Moderna in March released trial data that showed a two-dose formulation of its vaccine was safe and generated a similar immune response in young children as in adults.
The FDA's independent advisers will discuss the two applications in a meeting set for June 14-15!
$MRNA
The findings mean the outbreak likely will be difficult to contain, said Dr. Angela Rasmussen, a virologist at the University of Saskatchewan.
https://abcnews.go.com/Technology/wireStory/officials-find-monkeypox-strains-us-85165574
Simple math: the average selling price for a $SIGA course ~$525 * 190,000 = $99M in revenue!
SIGA Technologies over the past 20+ Days is receiving 3X More Calls than Puts
Calls are Averaging around 30,000
Puts are Averaging 10,000
This shows just how many people, Insiders and Institutions are Bullish
US CDC has issued a Level 2 Travel Alert about Monkeypox: may rise to Level 3 shorty...
https://wwwnc.cdc.gov/travel/notices/alert/monkeypox
I just dug deep and did math on cost per pill.
Two pills a day for 14 days, which is called a "course".
Delivery to the Strategic National Stockpile (SNS) of a limited number of courses (approximately 35,700 courses) of the oral formulation of TPOXX (oral TPOXX) for an approximate value of $11 million; such courses being readily-available for delivery or will be manufactured using currently-held active pharmaceutical ingredient.
Delivery of bulk drug substance to be used for the manufacture of IV TPOXX and the use of such bulk drug substance to manufacture 20,000 courses of final drug product of IV TPOXX, with such activities having a total value of $8 million for 7-day (14-vial) courses; additionally, SIGA will be paid for the storage, if applicable, and delivery of final drug product of IV TPOXX.
https://investor.siga.com/news-releases/news-release-details/siga-technologies-awarded-barda-contract-tpoxxr
Genetic data indicate at least two separate monkeypox outbreaks underway, suggesting wider spread:
https://www.statnews.com/2022/06/03/genetic-data-indicate-at-least-two-separate-monkeypox-outbreaks-underway-suggesting-wider-spread/
June 3, 2022 01:27 PM EDT Pharma
CDC treats first monkeypox patient with SIGA's smallpox antiviral via expanded accessgreat news, I can only imagine the deals that have been writen up today , we have our CEO in the right place at the right time . Going to be a great week next week for sure.
EU Medicines Agengy in talks to procure SIGA antiviral.
👉Tecovirimat is an #antiviral authorised to treat smallpox, #monkeypox and cowpox.
— EU Medicines Agency (@EMA_News) June 2, 2022
👉Imvanex is a vaccine currently only authorised in the 🇪🇺 to protect adults against smallpox, but animal data show effectiveness in the prevention of monkeypox.
Half way through pride month we will see an explosion of cases. I’m betting minimum 5000+ infected by the end of the month.
short term price action is irrelevant.
-Monkeypox community spread confirmed. It’s already global, WHO admits they don’t know if they can contain it.
they’re going to get orders larger than their entire market cap!
OS 72M
FLOAT 47M
CAP 913.77M
32,48% Institutional Ownership
we are ready for voyage of many days$$$$$$$$
$SIGA They are presenting at 2:20pm which is around 8:20AM EST.
https://cdn.who.int/media/docs/default-source/blue-print/agenda_monkeypox-research-priorities_june2022_webversion.pdf?sfvrsn=8839dc71_3
Looks like we need to break through that $13.40 level ... we’ve hit it twice this week! Treading water until contract announcement!
I am immortal....vaccinated with moderna!!!!!!!
let's see what happens today, we are, on the launch pad!
The Minister of Health, Carolina Darias, has announced that Spain has received this Thursday the first antivirals against monkeypox. It is a drug called tecovirimat, manufactured by the American pharmaceutical company SIGA and marketed under the name of Tpoxx
https://argentina.detailzero.com/news/9415/Spain-receives-the-first-treatments-against-monkeypox.html
Moderna continues to expect advanced purchase agreements of approximately $21 billion for 2022 and continues to believe that COVID market dynamics will result in sales slightly higher in the second half of 2022 than in the first half.
https://finance.yahoo.com/news/moderna-european-commission-agree-amendment-103000567.html
money machine$$$$$$$$
the world cannot end, human being can die!
The spokesman said the number of children presenting for respiratory distress, due to conditions such as COVID-19, influenza and respiratory syncytial virus, spiked 78 per cent in May compared to the previous month.
Queensland Children's Hospital under strain with spike in flu and respiratory cases
in australia, the cold season has arrived.......
this is the result......it's written on the wall
bad news
https://www.abc.net.au/news/2022-06-02/qld-coronavirus-covid19-flu-childrens-hospital-under-pressure/101117072
"In the CAR, 14 people with monkeypox have received an experimental drug, tecovirimat, as part of a trial launched by the University of Oxford in July 2021. “We’ve had very good results,” says Nakouné, who says he expects the data to be published within the next few weeks. The drug’s manufacturer, SIGA, has pledged to provide up to 500 treatment courses to the country."
https://www.science.org/content/article/monkeypox-is-a-new-global-threat-african-scientists-know-what-the-world-is-up-against#.YpfPGwShqm0.twitter
COVID-19 is here to stay, Whoever was questioning revenue for 2023/24/25
https://www.oregonlive.com/coronavirus/2022/05/expect-chronic-covid-yearly-booster-shots-fauci-says.html
Lazard Asset Management Llc increased their holdings by 3,193%, one of the largest institutional increases this quarter
https://insider-analysis.com/search_whales.php?ticker=TABLE_SIGA
In the recent reporting quarter: 8 institutions initiated a position, while 21 completely liquidated
21 institutions fucked up if they didn't rebuy !!!!!!!!!!!!
https://insider-analysis.com/search_whales.php?ticker=TABLE_SIGA
$SIGA
Tecovirimat vs brincidofovir. From UK research, Tecovirimat is proven to be better able to treat a patient. Brincidofovir has been observed to cause liver damaged during the treatment process!
https://www.medicalnewstoday.com/articles/monkeypox-small-study-points-to-a-promising-antiviral
This is getting completely insane! Monkeypox appears to be spreading from person to person in England, the UK Health Security Agency (UKHSA)
The current outbreak is the first time that the virus has been passed from person to person in England where travel links to an endemic country have not been identified.
SIGA could receive orders totaling more than their current market cap…with a float of 40 million this could go to absolutely bonkers levels
https://www.gov.uk/government/news/ukhsa-latest-findings-into-monkeypox-outbreak
paperwork expected to be signed on Wednesday-Thursday!
"But it will go quickly. We should have a contract ready in a week or so and maybe some limited deliveries in June," the paper quoted him saying.
https://www.reuters.com/world/europe/eu-agrees-common-purchase-vaccine-antiviral-against-monkeypox-paper-2022-05-27/
mRNA could revolutionize medicine
Scientists have been studying mRNA for decades. And mRNA vaccines are just the start
$MRNA
WHO warns of further transmission of monkeypox over summer
"the WHO doesn’t know shit about monkeypox "
https://odishatv.in/news/international/who-warns-of-further-transmission-of-monkeypox-over-summer-178063
GM man, yesterday nice volume BIG buy !!!!!!!!!
$ 1,218,713,852 vol. 8,343,905
moving$$$$$$$
Moderna has filed with the FDA seeking authorization for a two-dose regimen of its vaccine, called Spikevax, in children ages 6 months to 6 years old. Pfizer has not yet completed its FDA authorization application but its clinical trial tested a three-dose course of the vaccine for children ages 6 months to under 5 years old.
June 14 will be the new meeting date for the FDA and its advisory committee of external experts to discuss Moderna’s EUA request for 6 years through 17 years of age.
June 15 will be the new meeting date for the Moderna EUA request for 6 months through 5 years
CDC is closely tracking cases of monkeypox that have been recently reported in several countries that don’t normally have monkeypox activity, including the United States.
They are worried too!
https://www.cdc.gov/poxvirus/monkeypox/response/2022/index.html
Research scientists publish first head-to-head comparison of four COVID-19 vaccinesAntibodies: After six months, those given Moderna had highest levels of neutralizing antibodies, followed by those given the Pfizer-BioNTech and Novavax vaccines. The Janssen/J&J vaccine led to the lowest neutralizing antibody levels.
B cells: Participants given the Janssen/J&J vaccine had the highest percentage of memory B cells after six months.
CD4+ T cells: All participants retained a similar percentage of memory CD4+ "helper" T cells against the virus.
CD8+ T cells: The Novavax vaccine led to the lowest levels of CD8+ "killer" T cells. A higher CD8+ response was seen in those given Pfizer-BioNTech, Moderna, or Janssen/J&J vaccines. Overall, after six months, only 60 to 70 percent of participants retained memory CD8+ T cells.
updating!